ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Colon Cancer Survival Rates Differ Across Racial Lines

October 28, 2011

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004

Fewer Side Effects With IMRT Than Traditional Radiation

August 31, 2007

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003

NCI Posts Website Usability Research, Information Online.

January 12, 2001

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000